Search Results for “” – Page 75 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

1306 Publications found

A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.

b

Pregnancy hypertension

October 1, 2018

p Preeclampsia

c Change patient management Highlighted Observational
Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.

b

Pregnancy hypertension

October 1, 2018

p Preeclampsia

c Change patient management Clinical outcomes Highlighted Observational
Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer.

b

Lung cancer (Amsterdam, Netherlands)

October 1, 2018

p Cancer

c Economics
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.

b

Diabetes care

October 1, 2018

p Diabetes

c Change patient management RCT
ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes.

b

Pediatric diabetes

October 1, 2018

p Diabetes

c Clinical outcomes Guideline
ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes.

b

Pediatric diabetes

October 1, 2018

p Diabetes

c Change patient management Guideline
ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents.

b

Pediatric diabetes

October 1, 2018

p Diabetes

c Guideline
ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes.

b

Pediatric diabetes

October 1, 2018

p Diabetes

c Change patient management Guideline
High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.

b

Lancet (London, England)

September 15, 2018

p Cardiovascular Disease

c Clinical outcomes RCT
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial.

b

The Lancet. Respiratory medicine

September 1, 2018

p Cancer

c Change patient management Clinical outcomes Observational